Impact of COVID-19 on drug markets, drug use, drug-related harms and responses in south European Neighbourhood Policy countries


Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments. To investigate the effects of the pandemic on and the implications for drug markets and people who use drugs in the European Neighbourhood Policy (ENP) countries, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launched a trendspotter study. This briefing provides a snapshot of the state of play with respect to the impact of COVID-19 on drug markets and people who use drugs in south ENP countries (between March and June 2020).

A summary of the report is available in French, Arabic and Hebrew (see below).

Download as PDF

Table of contents

  • Summary
  • Introduction
  • The trendspotter methodology
  • Presentation and interpretation of the results
  • References
  • Resources